RecruitingNCT04224389

IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell Carcinomas

Prospective Non-randomized Comparative Study Between IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell Carcinomas of Early Local Stage of Oropharynx


Sponsor

Gustave Roussy, Cancer Campus, Grand Paris

Enrollment

150 participants

Start Date

Jun 22, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

Compare patients' feelings in terms of swallowing ability assessed by the overall score of MD Anderson Dysphagia Inventory (MDADI) 2 years after starting treatment between patients who have been treated with IMRT and those who were treated by transoral surgery for a squamous cell carcinoma of the early stage oropharynx.


Eligibility

Min Age: 18 Years

Inclusion Criteria9

  • Age ≥ 18 years old
  • ECOG performance status 0-2
  • Histologically confirmed squamous cell carcinoma
  • Primitive localization of the oropharynx on the tonsil compartment or the tongue base
  • p16 or HPV status available
  • TNM classification AJCC7th T1 or T2
  • TNM classification AJCC7th N0 or N1
  • Patient and tumor that can be treated by radiotherapy or by transoral surgery
  • Patient who has not objected to participate after being informed about the study. The patient must be able and willing to cooperate in follow-up and study visits

Exclusion Criteria10

  • Severe medical comorbidity or other contraindication to radiotherapy or surgery
  • Primary tumor or unresectable lymphadenopathy
  • Metastatic disease
  • History of squamous cell carcinoma of the head and neck within 5 years
  • History of radiation therapy to the head and neck
  • Inability to undergo or complete radiation therapy follow-up consultations
  • History of cancer except free of any disease for at least 5 years, with the exception of non-melanoma skin cancers
  • Inability to complete questionnaires
  • Pregnant or lactating woman
  • Patient under tutorship or curatorship, deprived of liberty or unable to do so to express consent

Interventions

PROCEDUREtransoral resection

The technique of transoral surgery will be left to the choice of the surgeon according to the equipment and the experience of the team and will be gathered. The options are: transoral surgery robot-assisted, endoscopic laser transoral surgery, transoral laser surgery classical instruments. The exact description of the resected area will be collected. of the cross-sections will be made for extemporaneous analysis if necessary in lateral margins and deep until complete excision.

RADIATIONIMRT

Intensity modulation radiotherapy (RCMI or IMRT) will be performed using techniques static or rotational (arctherapy, tomotherapy). Restraint is recommended with thermoformed mask


Locations(16)

CHU Montpellier

Montpellier, France

Gustave Roussy

Villejuif, Val De Marne, France

Centre Hospitalier InterCommunal

Créteil, France

Centre Oscar Lambret

Lille, France

Hôpital la Croix Rousse

Lyon, France

Centre Léon Bérard

Lyon, France

CHU Conception

Marseille, France

CHU Nantes - Hôtel Dieu

Nantes, France

Institut Universitaire de la face et du cou

Nice, France

Hôpital Européen Georges Pompidou

Paris, France

CHU Reims

Reims, France

Hôpital Charles Nicolle

Rouen, France

CHU Hôpital de Hautepierre

Strasbourg, France

Institut Claudius Regaud

Toulouse, France

CHU Tours

Tours, France

CHRU Nancy - Hôpital de Brabois

Vandœuvre-lès-Nancy, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04224389


Related Trials